26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one clinical trial despite the World Health Organisation’s decision to discontinue its own clinical study into the medication on safety grounds.

Two major clinical trials are underway in Australia to test hydroxychloroquine’s effectiveness, one as a treatment for COVID-19 and the other as a preventative. 

The trials have been funded despite the publication of several studies that have highlighted safety concerns over hydroxychloroquine.

Read The Australian article